| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2997 | |||||||||||||||||||||||
| Submitter : | Mrs. Staci Chronister | Date & Time: | 12/12/2006 09:12:26 | |||||||||||||||||||||
| Organization : | Mrs. Staci Chronister | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I would like the FDA guidance to direct companies not to use aborted fetal cells in the manufacturing of their vaccines. The use of such cells is unethical. There are ethical means available for vaccine production. | ||||||||||||||||||||||||